Latest papers

Statins and all-cause mortality in high-risk primary prevention: a second look at the results.

Time-dependent changes in the expression of lymphocyte and monocyte cell adhesion molecules after meals of different composition.

Low high-density lipoprotein cholesterol as the possible risk factor for stroke.

Good news for 'good' cholesterol.

Anti-inflammatory properties of high-density lipoprotein cholesterol in chronic hemodialysis patients: impact of intervention.

[On the current debate on lowering LDL cholesterol with ezetimibe].

What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease?

[On the current debate on lowering LDL cholesterol with ezetimibe].

Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS).

Veteran tobacco use, low-density lipoprotein, and glycated hemoglobin levels.

Antioxidant and antiatherogenic activities of pentacyclic triterpenic diols and acids.

Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions.

Combined effect of longevity-associated mitochondrial DNA 5178 C/A polymorphism and coffee consumption on the risk of hyper-LDL cholesterolemia in middle-aged Japanese men.

Relationship between low-density lipoprotein cholesterol level on admission and in-hospital mortality in patients with ST-segment elevation myocardial infarction, with or without diabetes, treated with percutaneous coronary intervention.

Animal models of atherosclerosis: more than mice.

Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension.

Exercise training accelerates the removal from plasma of LDL-like nanoemulsion in moderately hypercholesterolemic subjects.

Relationship of the polyunsaturated to saturated fatty acid ratio to cardiovascular risk factors and metabolic syndrome in Japanese: the INTERLIPID study.

Benefits of statin therapy and compliance in high risk cardiovascular patients

Association between lowering low-density lipoprotein cholesterol with pravastatin and primary prevention of cardiovascular disease in mild to moderate hypercholesterolemic Japanese.